Multi-omics Biomarker Pipeline Reveals Elevated Levels of Protein-glutamine Gamma-glutamyltransferase 4 in Seminal Plasma of Prostate Cancer Patients-Reference-Cited by-同舟云学术

Multi-omics Biomarker Pipeline Reveals Elevated Levels of Protein-glutamine Gamma-glutamyltransferase 4 in Seminal Plasma of Prostate Cancer Patients

Published:2019-09 Issue:9 Volume:18 Page:1807-1823
ISSN:1535-9476
Container-title:Molecular & Cellular Proteomics
language:en
Short-container-title:Molecular & Cellular Proteomics

Author:

Drabovich Andrei P.^ORCID,Saraon Punit^ORCID,Drabovich Mikalai,Karakosta Theano D.,Dimitromanolakis Apostolos,Hyndman M.Eric,Jarvi Keith,Diamandis Eleftherios P.^ORCID

Funder

Gouvernement du Canada | Canadian Institutes of Health Research (CIHR)

Prostate Cancer Canada (PCC)

Publisher

Elsevier BV

Subject

Molecular Biology,Biochemistry,Analytical Chemistry

Reference77 articles.

1. Global cancer statistics;Jemal;CA Cancer J. Clin,2011

2. Radical prostatectomy versus observation for localized prostate cancer;Wilt;N. Engl. J. Med,2012

3. ERSPC Investigators Screening and prostate-cancer mortality in a randomized European study;Schroder;N. Engl. J. Med,2009

4. One man at a time–resolving the PSA controversy;McNaughton-Collins;N. Engl. J. Med,2011

5. Comparison of the incidence of latent prostate cancer detected at autopsy before and after the prostate specific antigen era;Konety;J. Urol,2005

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification and Quantification of Human Relaxin Proteins by Immunoaffinity-Mass Spectrometry;Journal of Proteome Research;2024-05-13

2. Identification and quantification of human relaxin proteins by immunoaffinity-mass spectrometry;2024-01-13

3. Recent Advances of Ultrasound-Based Nano-Delivery Systems in Prostate Cancer Imaging and Treatment;2024

4. Multiplexed quantitative proteomics in prostate cancer biomarker development;Advances in Cancer Research;2024

5. Development of a predictive model to distinguish prostate cancer from benign prostatic hyperplasia by integrating serum glycoproteomics and clinical variables;Clinical Proteomics;2023-11-21